Abstract��OBJECTIVE To explore standardized pharmaceutical care service mode from establishment of process for pregnancy combined with hypothyroidism or hyperthyroidism. METHODS According to evidence-based medicine, relevant regulations and clinical practice, the pharmaceutical care process was established and tried out based on the clinical pharmacists�� daily work. We used METHODS of pharmaceutical care classification and standard record forms to carry out the systematic, real-time and continuous medical supervision work for patients. RESULTS Pharmaceutical care was performed on forty-two patients with hypothyroidism or hyperthyroidism in accordance with this procedure. Clinical pharmacists participated in the optimization of drug treatment regimens, intervened with irrational use of drugs, and advised on drug adverse reactions. CONCLUSION The practice of pharmaceutical care process is beneficial for clinical pharmacists to carry out pharmaceutical service in depth and ensure the safety of drug use. Standardization can promote this procedure in the industry field, as well as promote the improvement and homogenization of professional skill level and pharmacy service ability of clinical pharmacists in gynecology and obstetrics.
������, ������, ������, ������, ���, ��Խ. ̽������ϲ���״�ٹ��ܼ��˻�����ҩѧ�����[J]. �й�ҩѧ��־, 2018, 53(7): 561-564.
WANG Meng-meng, PANG Yan-yu, YANG Zhen-yu, WANG Xian-li, SUN Hui, WU Yue. Exploration of Pharmaceutical Care Process for Pregnancy Combined with Hypothyroidism or Hyperthyroidism. Chinese Pharmaceutical Journal, 2018, 53(7): 561-564.
AHMAD S, GERACI S A, KOCH C A. Thyroid disease in pregnancy: women��s health series[J]. South Med J, 2013, 106(11): 532-538.
[2]
The American College of Obstetricians and GynecologistsPractice Bulletin No. 148: thyroid disease in pregnancy[J]. Obstet Gynecol, 2015, 125(4): 996-1005.
[3]
ALEXANDER E K, PEARCE E N, BRENT G A, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum[J]. Thyroid, 2017, 27(3):315-389.
[4]
Chinese Society of Endocinology, Chinese Society of Perinatal Medicine. Guidelines for the Diagnosis and Treatment of Thyroid Diseases in Pregnancy and Postpartum[J]. Chin J Perinat Med(�л�Χ��ҽѧ��־), 2012, 15(7): 385-403.
[5]
COUCH K A, GEIDE T. ASHP Therapeutic position statement on strategies for identifying and preventing pneumococcal resistance[J]. Am J Health Syst Pharm, 2014, 71(5):417-424.
[6]
TANG H B, JIANG M, ZHOU J Y, et al. Key support study of medical staff for obstetric on pharmaceutical service pathway for pregnant and delivery women[J]. Chin Pharm J(�й�ҩѧ��־), 2014,49(24): 2230-2233.
[7]
LUO L F, DAI H B. Literature analysis on pharmaceutical care in China[J]. Chin Hosp Pharm J (�й�ҽԺҩѧ��־), 2017,37(4):319-321.
[8]
SUN F Y, LIU T. Research status and analysis of graded nursing in China[J]. Nur Pract Res(����ʵ�����о�), 2017, 14(8): 27-29.
[9]
BU Y S, XU Y G, CHEN F, et al. Study on development and implementation of grading pharmaceutical care[J]. Chin Hosp Pharm J (�й�ҽԺҩѧ��־), 2015,35(24):2163-2165.
2018, Vol. 53 
